Moreover, in vivo inhibition of NFAT decreased the retinal vascular expression of OPN and ICAM-1, prevented diabetes-induced retinal downregulation of the anti-inflammatory cytokine IL-10, and eliminated the phenomenon of increased vascular permeability in diabetic mice. The gene discussed is SPP1; the disease is diabetes mellitus.